Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 679

1.

Antimicrobial Resistance: We Must Pursue a Collaborative, Global Approach and Use a "One Health" Approach.

Lonsdale DO, Lipman J.

Antibiotics (Basel). 2019 Nov 27;8(4). pii: E237. doi: 10.3390/antibiotics8040237.

2.

Survey of critical care practice in Australian and New Zealand burn referral centres.

Holley AD, Reade MC, Lipman J, Delaney A, Udy A, Lee R, Litton E, Cheung W, Turner A, Garside T, Macken L, Reddi B, Kol M, Kazemi A, Shah A, Townsend S, Cohen J.

Crit Care Resusc. 2019 Dec;21(4):303-304. No abstract available.

PMID:
31778638
3.

Impact of preoperative duration of ulcerative colitis on long-term outcomes of restorative proctocolectomy.

Lavryk OA, Stocchi L, Hull TL, Lipman JM, Shawki S, Holubar SD, Delaney CP, Steele SR.

Int J Colorectal Dis. 2019 Nov 23. doi: 10.1007/s00384-019-03449-1. [Epub ahead of print]

PMID:
31760437
4.

Corrigendum to "Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study" [Journal of Critical Care 52 (2019) 75-79].

Dhaese SAM, Thooft ADJ, Farkas A, Lipman J, Verstraete AG, Stove V, Roberts JA, De Waele JJ.

J Crit Care. 2019 Nov 15. pii: S0883-9441(19)31431-5. doi: 10.1016/j.jcrc.2019.09.020. [Epub ahead of print] No abstract available.

PMID:
31740024
5.

A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study.

Parker SL, Pandey S, Sime FB, Lipman J, Roberts JA, Wallis SC.

Anal Bioanal Chem. 2019 Nov;411(29):7831-7840. doi: 10.1007/s00216-019-02184-4. Epub 2019 Nov 16.

PMID:
31732787
6.

Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research study.

Pandey S, Dhanani J, Lipman J, Roberts JA, Wallis SC, Parker SL.

Clin Chem Lab Med. 2019 Nov 12. pii: /j/cclm.ahead-of-print/cclm-2019-0780/cclm-2019-0780.xml. doi: 10.1515/cclm-2019-0780. [Epub ahead of print]

PMID:
31714883
7.

β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill.

Wong G, Taccone F, Villois P, Scheetz MH, Rhodes NJ, Briscoe S, McWhinney B, Nunez-Nunez M, Ungerer J, Lipman J, Roberts JA.

J Antimicrob Chemother. 2019 Oct 26. pii: dkz437. doi: 10.1093/jac/dkz437. [Epub ahead of print]

PMID:
31665353
8.

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.

Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D; Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine.

Intensive Care Med. 2019 Dec;45(12):1703-1717. doi: 10.1007/s00134-019-05819-3. Epub 2019 Oct 29.

9.

A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration.

Sime FB, Lassig-Smith M, Starr T, Stuart J, Pandey S, Parker SL, Wallis SC, Lipman J, Roberts JA.

Antimicrob Agents Chemother. 2019 Oct 28. pii: AAC.01655-19. doi: 10.1128/AAC.01655-19. [Epub ahead of print]

10.

Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients.

Yadav R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, Wallis SC, Huang Y, Bulitta JB, Paterson DL, Lipman J, Nation RL, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01679-19. doi: 10.1128/AAC.01679-19. [Epub ahead of print]

PMID:
31636062
11.

Pharmacokinetics of Total and Unbound Cefazolin during Veno-Arterial Extracorporeal Membrane Oxygenation: A Case Report.

Dhanani JA, Lipman J, Pincus J, Townsend S, Livermore A, Wallis SC, Abdul-Aziz MH, Roberts JA.

Chemotherapy. 2019;64(3):115-118. doi: 10.1159/000502474. Epub 2019 Oct 14.

PMID:
31610538
12.

A Multicenter Trial of Vena Cava Filters in Severely Injured Patients. Reply.

Ho KM, Rogers FB, Lipman J.

N Engl J Med. 2019 Oct 10;381(15):1496-1497. doi: 10.1056/NEJMc1911302. No abstract available.

PMID:
31597036
13.

Lefamulin. Comment on: "Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270".

Koulenti D, Xu E, Yin Sum Mok I, Song A, Karageorgopoulos DE, Armaganidis A, Lipman J, Tsiodras S.

Microorganisms. 2019 Sep 24;7(10). pii: E386. doi: 10.3390/microorganisms7100386.

14.

A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa.

Ballot DE, Bandini R, Nana T, Bosman N, Thomas T, Davies VA, Cooper PA, Mer M, Lipman J.

BMC Pediatr. 2019 Sep 7;19(1):320. doi: 10.1186/s12887-019-1709-y.

15.

Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion.

Dhaese SAM, Colin P, Willems H, Heffernan A, Gadeyne B, Van Vooren S, Depuydt P, Hoste E, Stove V, Verstraete AG, Lipman J, Roberts JA, De Waele JJ.

Int J Antimicrob Agents. 2019 Dec;54(6):741-749. doi: 10.1016/j.ijantimicag.2019.08.024. Epub 2019 Aug 31.

PMID:
31479741
16.

Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms.

Koulenti D, Xu E, Mok IYS, Song A, Karageorgopoulos DE, Armaganidis A, Lipman J, Tsiodras S.

Microorganisms. 2019 Aug 18;7(8). pii: E270. doi: 10.3390/microorganisms7080270. Review.

17.

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction.

Sime FB, Lassig-Smith M, Starr T, Stuart J, Pandey S, Parker SL, Wallis SC, Lipman J, Roberts JA.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01265-19. doi: 10.1128/AAC.01265-19. Print 2019 Oct.

18.

Vena Cava filters in severely-injured patients: One size does not fit all.

Ho KM, Holley A, Lipman J.

Anaesth Crit Care Pain Med. 2019 Aug;38(4):305-307. doi: 10.1016/j.accpm.2019.07.003. No abstract available.

PMID:
31345402
19.

What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review.

Sumi CD, Heffernan AJ, Lipman J, Roberts JA, Sime FB.

Clin Pharmacokinet. 2019 Nov;58(11):1407-1443. doi: 10.1007/s40262-019-00791-z. Review.

PMID:
31325141
20.

When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit.

Denny KJ, De Wale J, Laupland KB, Harris PNA, Lipman J.

Clin Microbiol Infect. 2019 Jul 12. pii: S1198-743X(19)30396-9. doi: 10.1016/j.cmi.2019.07.007. [Epub ahead of print] Review.

PMID:
31306790
21.

Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration.

Economou CJP, Xie J, Comadira G, Richards B, Tallott M, Wallis SC, Ordoñez J, Lipman J, Roberts JA.

Int J Antimicrob Agents. 2019 Sep;54(3):351-355. doi: 10.1016/j.ijantimicag.2019.06.027. Epub 2019 Jul 4.

PMID:
31279852
22.

A Multicenter Trial of Vena Cava Filters in Severely Injured Patients.

Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, Holley A, Kop A, Geelhoed E, Corcoran T, Misur P, Edibam C, Baker RI, Chamberlain J, Forsdyke C, Rogers FB.

N Engl J Med. 2019 Jul 25;381(4):328-337. doi: 10.1056/NEJMoa1806515. Epub 2019 Jul 7.

PMID:
31259488
23.

How We Do It: Creation of a Low-Cost Endoscopic Skills Model for Fundamentals of Endoscopic Surgery Training.

Ritter KA, Leifer D, Orabi D, Prabhu A, French J, Lipman JM.

J Surg Educ. 2019 Nov - Dec;76(6):1456-1459. doi: 10.1016/j.jsurg.2019.06.005. Epub 2019 Jun 22.

PMID:
31235442
24.

Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN).

Ranganathan D, Abdul-Aziz MH, John GT, McWhinney BC, Fassett RG, Healy H, Kubler P, Lim A, Lipman J, Purvey M, Roberts M, Reyaldeen R, Ungerer J, Roberts JA.

Ther Drug Monit. 2019 Dec;41(6):703-713. doi: 10.1097/FTD.0000000000000658.

PMID:
31219949
25.

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients.

Sime FB, Byrne CJ, Parker S, Stuart J, Butler J, Starr T, Pandey S, Wallis SC, Lipman J, Roberts JA.

Crit Care. 2019 Jun 6;23(1):205. doi: 10.1186/s13054-019-2483-9.

26.

Does intermittent pneumatic compression PREVENT deep vein thrombosis in the ICU?

Laupland KB, Tabah A, Kelway C, Lipman J.

Anaesth Crit Care Pain Med. 2019 Aug;38(4):303-304. doi: 10.1016/j.accpm.2019.05.006. Epub 2019 May 31. No abstract available.

PMID:
31158528
27.

Clinical and design factors influence the survivorship of custom flange acetabular components.

Jones CW, Choi DS, Sun P, Chiu YF, Lipman JD, Lyman S, Bostrom MPG, Sculco PK.

Bone Joint J. 2019 Jun;101-B(6_Supple_B):68-76. doi: 10.1302/0301-620X.101B6.BJJ-2018-1455.R1.

PMID:
31146558
28.

Antibiotic exposure at the site of infection: principles and assessment of tissue penetration.

Jager NGL, van Hest RM, Lipman J, Roberts JA, Cotta MO.

Expert Rev Clin Pharmacol. 2019 Jul;12(7):623-634. doi: 10.1080/17512433.2019.1621161. Epub 2019 May 28. Review.

PMID:
31136211
29.

Educational Targets to Reduce Medication Errors by General Surgery Residents.

Chaitoff A, Strong AT, Bauer SR, Garber A, Landreneau JP, French J, Rothberg MB, Lipman JM.

J Surg Educ. 2019 Nov - Dec;76(6):1612-1621. doi: 10.1016/j.jsurg.2019.04.009. Epub 2019 May 10.

PMID:
31080123
30.

Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study.

Dhaese SAM, Thooft ADJ, Farkas A, Lipman J, Verstraete AG, Stove V, Roberts JA, De Waele JJ.

J Crit Care. 2019 Aug;52:75-79. doi: 10.1016/j.jcrc.2019.04.013. Epub 2019 Apr 9. Erratum in: J Crit Care. 2019 Nov 15;:.

PMID:
30986758
31.

Hepatic Cancers Overview: Surgical and Chemotherapeutic Options, How Do Y-90 Microspheres Fit in?

Gans JH, Lipman J, Golowa Y, Kinkhabwala M, Kaubisch A.

Semin Nucl Med. 2019 May;49(3):170-181. doi: 10.1053/j.semnuclmed.2019.01.001. Epub 2019 Feb 19. Review.

PMID:
30954182
32.

In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration.

T P Wan W, Guerra Valero Y, Choi GYS, Ordóñez Mejia JL, Wallis SC, Joynt GM, Lipman J, Gomersall CD, Roberts JA.

Int J Antimicrob Agents. 2019 Aug;54(2):261-264. doi: 10.1016/j.ijantimicag.2019.03.018. Epub 2019 Mar 21.

PMID:
30904466
33.

Analysis of capillary microsamples obtained from a skin-prick to measure vancomycin concentrations as a valid alternative to conventional sampling: A bridging study.

Guerra Valero YC, Roberts JA, Lipman J, Fourie C, Starr T, Wallis SC, Parker SL.

J Pharm Biomed Anal. 2019 May 30;169:288-292. doi: 10.1016/j.jpba.2019.03.018. Epub 2019 Mar 9.

PMID:
30889434
34.

Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia.

Weber N, Jackson K, McWhinney B, Ungerer J, Kennedy G, Lipman J, Roberts JA.

J Infect Chemother. 2019 Jul;25(7):503-508. doi: 10.1016/j.jiac.2019.02.014. Epub 2019 Mar 15.

PMID:
30879981
35.

A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.

Lipman J, Brett SJ, De Waele JJ, Cotta MO, Davis JS, Finfer S, Glass P, Knowles S, McGuinness S, Myburgh J, Paterson DL, Peake S, Rajbhandari D, Rhodes A, Roberts JA, Shirwadkar C, Starr T, Taylor C, Billot L, Dulhunty JM.

Crit Care Resusc. 2019 Mar;21(1):63-68.

PMID:
30857514
36.

Correction to: The relationship between ventilator-associated pneumonia and chronic obstructive pulmonary disease: What is the current evidence?

Koulenti D, Parisella FR, Xu E, Lipman J, Rello J.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):649. doi: 10.1007/s10096-019-03518-x.

PMID:
30820839
37.

Defining optimal dosing of ciprofloxacin in patients with septic shock.

Roberts JA, Alobaid AS, Wallis SC, Perner A, Lipman J, Sjövall F.

J Antimicrob Chemother. 2019 Jun 1;74(6):1662-1669. doi: 10.1093/jac/dkz069.

PMID:
30809648
38.

Challenges in the management of septic shock: a narrative review.

De Backer D, Cecconi M, Lipman J, Machado F, Myatra SN, Ostermann M, Perner A, Teboul JL, Vincent JL, Walley KR.

Intensive Care Med. 2019 Apr;45(4):420-433. doi: 10.1007/s00134-019-05544-x. Epub 2019 Feb 11. Review.

PMID:
30741328
39.

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.

Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF.

Clin Infect Dis. 2019 Nov 13;69(11):1912-1918. doi: 10.1093/cid/ciz093.

PMID:
30722013
40.

The relationship between ventilator-associated pneumonia and chronic obstructive pulmonary disease: what is the current evidence?

Koulenti D, Parisella FR, Xu E, Lipman J, Rello J.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):637-647. doi: 10.1007/s10096-019-03486-2. Epub 2019 Jan 24. Review. Erratum in: Eur J Clin Microbiol Infect Dis. 2019 Feb 28;:.

PMID:
30680576
41.

Gender and Letters of Recommendation: A Linguistic Comparison of the Impact of Gender on General Surgery Residency Applicants.

French JC, Zolin SJ, Lampert E, Aiello A, Bencsath KP, Ritter KA, Strong AT, Lipman JM, Valente MA, Prabhu AS.

J Surg Educ. 2019 Jul - Aug;76(4):899-905. doi: 10.1016/j.jsurg.2018.12.007. Epub 2018 Dec 28.

PMID:
30598383
42.

Postoperative Steroid Taper Is Associated With Pelvic Sepsis After Ileal Pouch-anal Anastomosis.

Ritter KA, Burke JP, Stocchi L, Aiello A, Holubar S, Ashburn JH, Lipman JM, Shawki S, Hull T.

Inflamm Bowel Dis. 2019 Jul 17;25(8):1383-1389. doi: 10.1093/ibd/izy388.

PMID:
30597024
43.

Recovery rates of combination antibiotic therapy using in vitro microdialysis simulating in vivo conditions.

Dhanani JA, Parker SL, Lipman J, Wallis SC, Cohen J, Fraser J, Barnett A, Chew M, Roberts JA.

J Pharm Anal. 2018 Dec;8(6):407-412. doi: 10.1016/j.jpha.2018.07.003. Epub 2018 Jul 6.

44.

Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit.

Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, Ñamendys-Silva SA, Martin-Loeches I, Leone M, Lupu MN, Vincent JL; ICON Investigators.

Open Forum Infect Dis. 2018 Nov 19;5(12):ofy313. doi: 10.1093/ofid/ofy313. eCollection 2018 Dec.

45.

The Use of Three-Dimensional Printing for Complex Scaphoid Fractures.

Jew N, Lipman JD, Carlson MG.

J Hand Surg Am. 2019 Feb;44(2):165.e1-165.e6. doi: 10.1016/j.jhsa.2018.10.018. Epub 2018 Dec 14. Review.

PMID:
30554739
46.

Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis.

Novello M, Stocchi L, Holubar S, Shawki S, Lipman J, Gorgun E, Hull T, Steele SR.

Int J Colorectal Dis. 2019 Mar;34(3):451-457. doi: 10.1007/s00384-018-3212-6. Epub 2018 Dec 10.

PMID:
30535559
47.

Mechanical performance of cementless total knee replacements: It is not all about the maximum loads.

Quevedo González FJ, Lipman JD, Lo D, De Martino I, Sculco PK, Sculco TP, Catani F, Wright TM.

J Orthop Res. 2019 Feb;37(2):350-357. doi: 10.1002/jor.24194. Epub 2019 Jan 3.

PMID:
30499604
48.

A comparison between raw and predicted mortality in a paediatric intensive care unit in South Africa.

Ballot DE, Ramdin T, White DA, Lipman J.

BMC Res Notes. 2018 Nov 26;11(1):829. doi: 10.1186/s13104-018-3946-9.

49.

Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.

Heffernan AJ, Sime FB, Lipman J, Dhanani J, Andrews K, Ellwood D, Grimwood K, Roberts JA.

Int J Antimicrob Agents. 2019 Mar;53(3):234-245. doi: 10.1016/j.ijantimicag.2018.11.011. Epub 2018 Nov 23.

PMID:
30472292
50.

Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?

Koulenti D, Song A, Ellingboe A, Abdul-Aziz MH, Harris P, Gavey E, Lipman J.

Int J Antimicrob Agents. 2019 Mar;53(3):211-224. doi: 10.1016/j.ijantimicag.2018.10.011. Epub 2018 Oct 27. Review.

PMID:
30394301

Supplemental Content

Loading ...
Support Center